E-resources
-
Masiá, Mar; Fernández-González, Marta; Telenti, Guillermo; Agulló, Vanesa; García, José A.; Padilla, Sergio; García-Abellán, Javier; Galiana, Antonio; Gonzalo-Jiménez, Nieves; Gutiérrez, Félix
Journal of autoimmunity, 09/2021, Volume: 123Journal Article
Durability of the humoral immune response to SARS-CoV-2 has yet to be defined. We longitudinally evaluated during a 12-month period the antibody responses to SARS-CoV-2, and analysed predictors of antibody titres decline and seroreversion. Prospective study conducted in a cohort of patients hospitalized for microbiologically-confirmed COVID-19. Blood and nasopharyngeal samples were sequentially obtained during hospital stay and at 1, 2, 6 and 12 months after patients’ discharge for measuring anti-spike (S) and anti-nucleocapsid (N) IgG antibody levels and SARS-CoV-2 RNA, respectively. 80 non-vaccinated patients were analysed. At month 12 after discharge, 73 (91.2%) patients exhibited detectable S-IgG and 35 (43.8%) N-IgG antibody titres. A gradual wane was observed in S-IgG and N-IgG antibody titres. Linear regression showed that S-IgG decline was positively associated with peak antibody titres (coefficient 95% CI 0.059 0.05–0.067, p < 0.001), inversely with WHO severity score (coefficient 95% CI −0.042 -0.079/-0.004, p = 0.033), and there was a trivial positive association with age (coefficient 95% CI 0.002 0–0.005, p = 0.10); N-IgG decline was positively associated with peak antibody titres (coefficient 95% CI 0.091 0.078–0.105, p < 0.001). Logistic regression showed that seroreversion for S-IgG was inversely associated with peak S-IgG (OR 0.19; 95% CI, 0.04-0.45; p = 0.004); seroreversion for N-IgG was inversely associated with peak N-IgG (OR 0.71; 95% 0.53–0.90; p = 0.009) and positively with cycle threshold of RT-PCR (OR 1.14; 95% CI, 1.00–1.33; p = 0.062). Anti-spike IgG antibodies remain detectable one year after hospitalization for COVID-19. Higher peak antibody titres and disease severity were associated with increased durability of detectable antibodies. •Postinfection humoral immunity may protect against SARS-CoV-2 reinfection.•Durability of the humoral immune response remains unknown.•Most COVID-19 patients show persistent S-IgG antibodies one year after hospitalization.•Durability of antibody response associated with higher peak titres and disease severity.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.